Member Info for Bladderman

On this evidence vet BGF are waiting for the SP to climb possibly above 100p before they do as they did so before. They converted at this price because they know it's cheap and can sell for a lot higher with anticpated news flow. Lots of news flow anticipated and still just under 50p to buy.

Would be very welcome news for GDR and our share price!

Good work Soltace - woukd very great news for GDR

£18k at 49p - should do well from these levels. Buy low sell high

Highly lucrative for GDR Technic. The market has been given a heads up

Yes this company is now debt free plus £5M ish cash.

All guess work but perhaps they have converted ahead of the £10M plus order that is an 'advanced opportunity'.

The last time these guys converted the SP went from 100 to 135p over a couple of weeks. My target by end of March is 100-150p so let's see how she plays

In a note to clients, analysts at City broker Peel Hunt repeated a 'buy' rating on the stock and said: "We continue to think that genedrive’s freeze-dried bead chemistry is ideally suited for use on high-throughput robotic platforms (its remains stable for hours after unsealing and does not require the fluid dispensing steps seen in other automated assays) giving it a crucial differentiator.

Nobody is twisting your arm Magic - if not for you then move on

Genedrive PLC (LON:GDR) shares jumped higher on Wednesday as it told investors that the US Food & Drug Administration (FDA) that it intends to import and distribute its 96 SARS-CoV-2 kit in the US prior to emergency use authorisation (EUA).

The company said it had taken the decision in order to support its collaboration agreement with Beckman Coulter that will see the pair bring to the market a fully automated coronavirus (COVID-19) testing solution. It also wants to “exploit commercial opportunities”.

“We are confident in the performance claims of our assay and have generated independent evaluation data in the United States at non-automated sites and our automated Biomek installations which confirm our product claims.”

I'm referring to Beckmans redudant robotics kit because they need our freeze dried tech to get these high through put testing platforms kicking out the COVID tests. The US need these robots in action as much as Beckman and of course the GDR shareholders. It's a win win

BTW i worked on an automated Panther machine in the UK three weeks ago so know how valuable these bits of kit can be. The US needs to increase tests 7 fold and we can contribute. If these things pan out we could be looking at £70M-£90M MCap easy. Sub £30M is literally a p**s take and doesn't David just know this. Today was a heads up - we have US data for the US market and they will be desperate for such tests due to demand and their budgets make a mockery of the UK and Beckham has the foot in the door so expect to succeed where NCYT failed

Forget the odd shorter or paid deramper. Loads of cash locked in higher. I scooped stock at 15%-20% off the low so I'm pleased. 2021 could be very special indeed for holders. Come January end I reckon we'll be knocking at 100p so let's see. The POC test and update will also be very positive for us. Thanks to Beckham there will be demand in the US. Lots of US labs have redundant machinery that will be brought into action usibg our fully automated readout o battle the pandemic. Up to 10k per day per machine. Now where's my calculator..!! This could be explosive for little MCap GDR

Like it or not the re-rate is coming. Lots of new money poured in today and we're going to have some more very big days ahead as we will be deemed very cheap compared to our competitors now that the US commercial roll out is happening. Thanks Beckham.

Four from the last 20 minutes at £12k a pop have popped up

GDR's kit for the fully automated testing machinery now US bound for commercial sell. Apparently we have generated US data for the US potential buyers. They need tests over there - especially fully automated tests ASAP whether a couple of posters here like it or not

Sales are inbound in my opinion now we commercially sell the product -

https://www.proactiveinvestors.co.uk/companies/amp/news/936673?__twitter_impression=true

Worth re-reading again

Total traded today .....3M
Undeclared trades almost 1M.

Sentiment reversal in play as well. Let's do 5-10% a day. Why not. It's almost 3x cheaper than ODX

Agreed - some people remember how cheap NCYT once was now it's close to £500 million and we are close to £30M. Test test test. Even at £60M is only a quid. Where it was valued only a month or so ago. At 50p to me seems to be a steel. Buy low sell high